Aidy
AboutFeaturesGalleryLearn

Partners

Patient ServicesMedical Affairs & HEORSpecialty Pharmacies
Healthcare Navigation

Your Personal IBD Baseline: The Eight Things to Record When You Feel Well

By the Aidy Editorial Team

First Published Jun 8, 2026Last Updated Jul 23, 2026

Your Personal IBD Baseline: The Eight Things to Record When You Feel Well

Most people with inflammatory bowel disease start tracking on their worst day. They open a notes app in the middle of a flare, record a week of misery, and abandon it once things settle. The problem with that habit is that a flare log has nothing to be measured against. Inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis, moves between periods of symptoms and periods of remission when symptoms fade, sometimes for weeks and sometimes for years, according to the National Institute of Diabetes and Digestive and Kidney Diseases. The well period is the useful one to document. This guide covers eight things worth recording as your personal IBD baseline while you feel fine.

Why remission is the right time to write things down

A baseline turns vague reporting into comparison. "More bathroom trips than usual" means little to a gastroenterologist. "Three a day now, one a day for the past eight months" is a data point. Severity in ulcerative colitis is described partly in terms of daily bowel movement counts, with mild disease involving fewer than four a day and severe disease more than six, so your own count matters clinically as a starting number.

Objective measures matter too. The American Gastroenterological Association recommends monitoring people in symptomatic remission with a combination of biomarkers and symptoms rather than symptoms alone, because inflammation can continue quietly when a person feels well. The international STRIDE-II treat-to-target framework sets symptomatic relief and normalization of blood and stool markers as short-term goals, with endoscopic healing and restored quality of life as long-term ones. A baseline you record yourself sits alongside those measures and gives them context.

What normal looks like in the bathroom

The first three items are the ones that change earliest. Item one is your typical bowel movement count on an ordinary day, plus your usual range across a week. Item two is stool form. The Bristol Stool Form Scale, a seven-point picture scale, has been shown to have substantial validity and reliability for classifying stool consistency, and naming a number is faster and more repeatable than describing texture in words. Note where you usually land.

Item three is urgency, meaning how much warning you get. Urgency is now measured formally in ulcerative colitis research using the Urgency Numeric Rating Scale, an eleven-point scale from zero for no urgency to ten for the worst possible urgency, scored over the past 24 hours and developed in line with Food and Drug Administration guidance for patient-reported outcomes. Give yourself a number today. Most people in remission sit at zero or one, and a persistent two or three later on is a signal worth reporting.

Blood, night symptoms, and your usual pain

Item four is bleeding and night-time bowel movements. Rectal bleeding, blood or mucus in stool, and a persistent urge to go are listed among the core symptoms of ulcerative colitis by the NIDDK, so record honestly whether you see any blood at all in a good month and whether anything wakes you at night. Zero is a valid and important entry.

Item five is abdominal pain in its baseline form. Many people in remission still have some cramping, often tied to meals or stress. Write down where it sits, how intense it usually is on a zero to ten scale, what time of day it arrives, and how long it lasts. When a change happens later, the useful question is whether the pain is in a new place, at a new intensity, or on a new schedule. That comparison is impossible without the original description.

Energy, mood, and weight

Item six is fatigue and sleep. Fatigue is not confined to flares. A meta-analysis in Clinical Gastroenterology and Hepatology found fatigue in 47% of adults with IBD in remission compared with 72% during active disease, with sleep disturbance, anxiety, depression, and anemia among the most commonly reported contributors. Record your usual sleep hours and rate a typical day's energy.

Item seven covers mood and weight together. A systematic review in The Lancet Gastroenterology & Hepatology put the pooled prevalence of anxiety symptoms at 32.1% and depression symptoms at 25.2% across 30,118 patients with IBD, with both higher during active disease. A baseline mood rating makes a later drift easier to name. Weight belongs here as well. Nutrition status is a formal part of IBD care in both active disease and remission under the ESPEN clinical nutrition guideline, and a stable well-period weight is the reference point for spotting unintended loss.

Your numbers, on paper, with dates

Item eight is the clinical record itself. Ask for your most recent results and write down the value and the date for fecal calprotectin, C-reactive protein, hemoglobin, ferritin, and albumin. Thresholds give these meaning. AGA guidance identifies fecal calprotectin under 150 micrograms per gram and CRP under 5 milligrams per litre as consistent with absent inflammation in people in symptomatic remission whose endoscopic remission has been confirmed, and the parallel ulcerative colitis guideline applies a comparable stool marker cutoff. For iron, the European Crohn's and Colitis Organisation consensus treats ferritin below 30 micrograms per litre as iron deficiency without inflammation, rising to 100 micrograms per litre when inflammation is present, and advises checking blood count, ferritin, and CRP every 6 to 12 months in people in remission. Record your medications, doses, and infusion or injection dates in the same place.

Keeping the baseline current

Two additions make the record more useful. Note any joint, skin, eye, or mouth symptoms you live with, since a meta-analysis of 352,454 patients found at least one joint, ocular, or skin extraintestinal manifestation in 24% of people with IBD. And date every entry, because a baseline written three years and two drug changes ago describes a different disease state than the one you have now. Revisit the eight items after any treatment change, any surgery, and at each annual review, then leave them alone. The value of a baseline comes from its being written when nothing was wrong, which is the one moment when almost nobody thinks to write anything down.

This article is for educational purposes and is not medical advice. It is researched against current AGA clinical guidelines and peer-reviewed sources. Always discuss treatment decisions with your care team.

Your IBD Coverage Call Script: 12 Questions to Ask Your Insurer